HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

MINNEAPOLIS, United States:   HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic

READ MORE

Edison Investment Research increases valuation of Cereno Scientific to 3.9 BSEK or SEK 13.9 SEK/share after positive topline data

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced

READ MORE